key: cord-0777043-lvewxgaz authors: Bavaro, D. F.; Diella, L.; Fabrizio, C.; Sulpasso, R.; Bottalico, I. F.; Calamo, A.; Santoro, C. R.; Brindicci, G.; Bruno, G.; Mastroianni, A.; Buccoliero, G. B.; Carbonara, S.; Lo Caputo, S.; Santantonio, T.; Monno, L.; Angarano, G.; Saracino, A. title: Peculiar clinical presentation of COVID- 19 and predictors of mortality in the elderly: a Multicentre Retrospective Cohort Study date: 2021-03-17 journal: Int J Infect Dis DOI: 10.1016/j.ijid.2021.03.021 sha: a4159162724d01784b5f7765b1a9e8f402ddc9e8 doc_id: 777043 cord_uid: lvewxgaz Background The spectrum of clinical manifestations of CoronaVirus Disease-19 (COVID-19) is not yet completely known. In elderly, mortality and extra-pulmonary involvement appear to be more frequent than expected. Methods A multicentric-retrospective-case-series of patients hospitalized between March 1st and June 15th, 2020 with confirmed COVID-19 by RT-PCR testing on throat/nasopharyngeal swabs and age ≥65 years was analysed. Based on the “Clinical Frailty Scale” (CFS), patients were classified into three groups according to the resulting score: 1-3 (group A), 4-6 (group B), 7-9 (group C). Results Overall, 206 patients were included. Crude mortality was 27%. According to CFS, on admission, 60 patients (29%) were assigned to group A, 60 (29%) to group B, and 86 (42%) to group C. The following features were significantly more frequent among group C patients in comparison with groups B and A: mental confusion (65% vs 33% vs 7%, respectively, p < .001), kidney failure (39% vs 22% vs 20%, p = .019), dehydration syndrome (55% vs 27% vs 13%, p < .001), electrolyte imbalance (54% vs 32% vs 25%, p = .001), and diabetic decompensation (22% vs 12% vs 7%, p = .026). By multivariable logistic regression model, male sex (aOR = 2.87, 95%CI = 1.15–7.18), CFS between 7 and 9 (aOR = 9.97, 95%CI = 1.82–52.99), dehydration at admission (aOR = 4.27, 95%CI = 1.72–10.57), and non-invasive/invasive ventilation (aOR = 4.88, 95%CI = 1.94–12-26) were independent predictors of death. Conclusions Elderly with a high CFS showed frequent extrapulmonary signsat admission, even in absence of lung involvement. These findings, along with a high CFS, predicted a significant risk of mortality. Since the end of 2019, a novel coronavirus named SARS-CoV-2 is currently being responsible for a dramatic outbreak of pneumonia cases (COVID-19) rapidly spreading worldwide. COVID-19 can arise with non-specific symptoms, like cough, fever, arthro-myalgia, sore throat; thereafter, the disease might evolve into pneumonia and progress further to acute respiratory distress syndrome (ARDS), a life-threatening condition [1] . During the pandemic, the elderly were particularly affected by severe forms of COVID-19, with a higher reported mortality than in younger subjects [2] [3] . Indeed, elderly are considered as a frail population, because of their increased vulnerability to endogenous and exogenous stressors [4] due to a dysregulated innate and adaptative immune function known as immunosenescence. Moreover, "inflamm-aging", that refers to a state of chronic low-grade inflammation, is related to an imbalance of anti-inflammatory and pro-inflammatory cytokines. [5] Recent studies suggested that, older adults present at diagnosis more often with extrapulmonary complications, even in absence of lung findings, if compared with younger subjects [6] ; notably a wide variety of manifestations were described, including acute kidney injury [7] , gastrointestinal symptoms [8] , acute pulmonary embolism [9] , and neurological complications [10] . Although data are still inconsistent, all these different factors could increase mortality in this special population; additionally, recent studies demonstrated that clinicians should also consider other aspects possibly influencing the overall risk of death. For instance, the Clinical Frailty Scale (CFS) showed to be a useful marker of mortality, independently of comorbidities [11] [12] . This association was further confirmed by a recent meta-analysis that also suggested a possible linear fashion between the increase in CFS and higher mortality [13] . Anyway, other Authors proposed caution in placing too much emphasis on the influence of frailty alone on the risk of mortality of older patients with COVID-19 [14] . Herein, we conducted a retrospective analysis of COVID- 19 Nasopharyngeal swabs were used to diagnose COVID-19 in all patients. Tests were performed at each hospital's laboratory using real-time reverse transcriptase PCR [real-time PCR assay targeting E-gene, RdRP-gene and N-gene, performed with the protocol previously reported by the WHO (https://www.who.int/docs/default-source/coronaviruse/uscdcrt-pcr-panel-for-detectioninstructions.pdf?sfvrsn=3aa07934_2)]. The Clinical Frailty Scale (CFS) is a validated scale summarizing the overall level of fitness or frailty of an older adult (over 65s only) based on the assessment of an experienced clinician [15] . The CFS is employed to predict the outcome of older people hospitalized with an acute illnesses and in-patient mortality. The CFS (Supplementary Table 1 ) numerically ranks frailty from 1 to 9 as not frail (scores 1-3), vulnerable (score 4), mildly frail (score 5), moderately frail (score 6), or J o u r n a l P r e -p r o o f severely frail (score 7-9). A visual chart assists with the frailty classification. The patient's level of disability heavily weights the CFS and the degree of frailty corresponds to the degree of dementia: mild, moderate and severe dementia generally map to CFS 5, 6 and 7 respectively. More importantly, the accuracy of this tool stands in the clinician's skills to evaluate the patient's baseline status before hospitalization. Accordingly, for the purposes of the study, patients were grouped as follows: group A (CFS score 1-3, fit), group B (score 4-6, vulnerable or mild-moderate frailty), and group C (score 7-9, severe or very severe frailty). V) Acute heart failure at admission: as defined by current European guidelines [17] . VI) Diabetic decompensation: persistent blood sugar levels of > 199 mg/dL despite antidiabetic therapy within first 48 h from admission. The above conditions were attributed to COVID-19 only if they were absent in the 2 weeks prior to admission. Moreover, previous comorbidities and clinical history of patients were used to include or not these variables in the final analysis. All data were anonymized and collected on an electronical database. Descriptive statistics were produced for demographic, clinical and laboratory characteristics of cases. Mean and standard deviation (SD) were obtained for normally distributed variables, and median and interquartile range (IQR) for non-normally distributed variables, number, and percentages for categorical variables. Survival analysis (Kaplan-Meier curves estimates) was performed to explore the impact of CFS or age on patient overall survival probability. Finally, univariate logistic regression was performed in order to assess predictors of mortality in elderly; then a stepwise multivariate logistic regression model was applied to control for potential confounders and was adjusted for variables associated (p value <0.1) at univariable analysis with endpoint at univariable analysis. Crude in-hospital mortality was 27%. Differences in clinical features of patients according to CFS and Age are shown in Table 1 . Overall, according to CSF, a total of 60 patients were assigned to group A (CFS 1-3), 60 to group B (CFS 4-6), and 86 patients to group C (CFS 7-9). Notably, elderly assigned to group C were less frequently male (33% vs 52% vs 65% respectively; p <.001), more frequently affected by neurologic diseases (38% vs 22% vs 5% respectively, p<.001), and resident in health care facilities (73% vs 47% vs 14% respectively, p <.001) than patients in groups B and A. At admission, they also presented with fever (42% vs 65% vs 65% respectively, p=.004) and cough (24% vs 40% vs 62% respectively, p <.001) less frequently than patients in groups B and A, and chest X-ray showed less frequently signs of pneumonia (p=.013). On the other hand, secondary infections during hospitalization were significantly associated with higher frailty score (13% vs 22% vs 36% in group A, B and C respectively; p=.006). Finally, a different survival rate was observed stratifying patients according to CFS (95% vs 73% vs 57% in group A, B and C respectively; p <.001). Differences in clinical features of patients were also evaluated after stratification into three groups according to age (65 to 74 years vs 75 to 84 years vs 85 years or more). Overall, older patients presented a higher median CFS score (2 vs 6 vs 7 respectively, p<.001) than younger subjects. Overall, differences between the three group were roughly conserved either if stratified according to age or to CSF score; however, the frequency of secondary infections during hospitalization appeared to correlate with CFS (p=.006) but not with age (p=.411). Extrapulmonary findings at admission, and their association with either CFS or age, are also presented in Table 1 . Older age was only related to a higher frequency of confusion and dehydration, whereas a higher CFS score defined a more complex clinical picture at admission. In fact, patients in group C (CFS score 7-9) were more frequently confused (65% vs 33% vs 7% respectively, p <.001), dehydrated (55% vs 27% vs 13%, p <.001), and more often they had decompensated diabetes (22% vs 12% vs 7%, p=.026), acute kidney failure (39% vs 22% vs 20%, p=.019), and electrolyte imbalance (54% vs 32% vs 25%, p=.001) at admission than patients in groups A and B. By conducting a univariable and a stepwise multivariable logistic regression model ( consequences they entail. In addition, in elderly patients, the mortality rate is relevant [18] [19] probably because they are more prone to develop severe pulmonary disease [20] ; however, few data are available about extra-pulmonary manifestations in this population and about their role in determining an increased mortality [21] . In this study involving patients older than 65 years, we described the clinical manifestations of COVID 19 at hospital admission and investigated their association with risk of in-hospital mortality. An interesting correlation between extra-pulmonary manifestations and "frailty", evaluated in terms of Clinical Frailty Scale score, was noticed. In fact, frailer patients presented more often with neurological or metabolic signs and symptoms, while fever, cough and lung infiltrates/consolidations were less frequent. Conversely, this association was not confirmed when we stratified clinical features at admission by different age groups. Hence, results of this study, along with previous ones [6 ; 22-23] indicated that the clinical picture of SARS-CoV-2 infection in the elderly could significantly be different from "usual" progressive hypoxemic pneumonia described in young or middle-aged patients. Consequently, the occurrence of acute extrapulmonary symptoms, even in absence of respiratory diseases including non-specific findings like general deterioration in older and frail subjects, should be actively investigated as a possible COVID-19. Theoretically, these findings might be explained by the different intensity of immune response to SARS-CoV-2 infection based on frailty level [24] ; indeed, immunosenescence, a typical phenomenon of older and frail individuals, may be responsible for a milder pulmonary cytokines release, that in turn, causes a reduced lung involvement and distress [25] . On the other side, the relatively high incidence of extrapulmonary manifestations in frailer patients could be due to the deterioration caused by SARS-CoV-2 infection of pre-existing comorbidities.]. Our data are in line with the current literature: in our cohort, both dehydration and a high CSF score (7-9) on admission were independent predictors of mortality, along with a severe pulmonary disease requiring non-invasive/invasive mechanical ventilation. Importantly, it should be noticed that the need of non-invasive/invasive mechanical ventilation reflects a serious lung impairment and disfunction related to COVID-19; therefore, it is not surprising its association with overall mortality, independently of CFS and other complications, particularly in our setting where no "do not treat on ICU" order was established a priori during the study period. According to a previous study [26] "frailty" is associated with higher mortality rates and longer hospital stay in COVID-19 patients. Moreover, similar to a previous observation [27] , confusion and altered mental status were often observed at admission; this complication might be considered both as a direct injury of SARS-CoV-2 to central nervous system or a sign of systemic impairment. Finally, also hyperglycemia [28] and acute kidney injury [29] were frequent complications of the frailest patients on presentation. Hence, these observations suggest a complex clinical picture Italy, the very detailed information regarding the clinical picture at the admission, and the quite well-balanced number of subjects included in the different CFS and age groups, which renders affordable the comparative analysis. The main limitations of this study are its retrospective nature, which possibly implies incomplete or missing data, and the relative limited number of subjects involved. In conclusion, this study suggest that elderly with a high CFS showed frequent extrapulmonary signs at admission, even in absence of lung involvement. These findings, along with a high CFS, predicted a significant risk of mortality. None. No author has any conflict of interest to declare. Legend: OR= odds ratio; aOR= adjusted odds ratio; boldface means statistically significant (p<.05). Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis Age-Related Morbidity and Mortality among Patients with COVID-19. Infect Chemother Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Frailty as a phenotypic manifestation of underlying oxidative stress Immunosenescence: Implications for response to infection and vaccination in older people COVID-19 in older adults: What are the differences with younger patients? Acute kidney injury in patients with COVID-19: an update on the pathophysiology Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis Occurrence of Acute Pulmonary Embolism in COVID-19-A case series Neurological injuries in COVID-19 patients: direct viral invasion or a bystander injury after infection of epithelial/endothelial cells Risk factors for death in adult COVID-19 patients: Frailty predicts fatal outcome in older patients Older age and frailty are the chief predictors of mortality in COVID-19 patients admitted to an acute medical unit in a secondary care setting-a cohort study Clinical frailty scale and mortality in COVID-19: A systematic review and dose-response meta-analysis What is the relationship between validated frailty scores and mortality for adults with COVID-19 in acute hospital care? A systematic review A global clinical measure of fitness and frailty in elderly people Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC Short-term outcomes in individuals aged 75 or older with severe coronavirus disease (COVID-19): First observations from an infectious diseases unit in Southern Italy Tocilizumab and corticosteroids for COVID-19 treatment in elderly patients Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients COVID 19 -Clinical Picture in the Elderly Population: A Qualitative Systematic Review Clinical feature of COVID-19 in elderly patients: a comparison with young and middle-aged patients Clinical characteristics and prognostic factors in COVID-19 patients aged ≥80 years Tocilizumab and corticosteroids for COVID-19 treatment in elderly patients Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune ResponseFront Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2complicated outcomes The effect of frailty on survival in patients with COVID-19(COPE): a multicentre Prevalence and prognostic value of Delirium as the initial presentation of COVID-19 in the elderly with dementia: An Italian retrospective study Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 StudyDiabetes Care Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct PathophysiologyJASNJul Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study 58 (28) 16 (27) 22 (37) 20 (23) .198 18 (29) 23 (32) 17 (24) .530Invasive Mechanical Ventilation during hospitalization -n (%) 14 (9) 6 (13) 4 (9) 4 (7).573 6 (13) 5 (10) 3 (6) .447